Published 2 years ago

UK is first to approve COVID vaccine targeting both original strain and Omicron variant

Summary by Ground News

Britain has become the first country to approve a COVID-19 vaccine that targets both the original and Omicron variant of the virus. The the UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna.

0 Articles

All

Left

Center

Right

Times of India

Variant-adapted Covid vaccine wins first approval in Britain

The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna as a booster for adults. The agency's decision was based on clinical trial data that showed the booster triggered "a strong immune response" against both Omicron (BA.1) and the original 2020 virus, it said.

2 years ago·India

Read Full Article

BBC News

Covid: UK first country to approve dual-strain vaccine

The bivalent vaccine will now form part of the booster campaign to be rolled out this autumn.

2 years ago·United Kingdom

Read Full Article

News18 India

In a First, Updated Moderna Vaccine That Targets Both 2020 & Omicron Variants Approved in UK

The ‘bivalent vaccine’, as it’s known, made by US drug company Moderna, was approved by the UK medicines regulator as a booster for adults

2 years ago·India

Read Full Article

The Guardian

Covid vaccine designed to target two variants approved for use in UK

JCVI will decide whether to use Moderna-manufactured jab in planned autumn booster campaign

2 years ago·London, United Kingdom

Read Full Article

CTV News

New COVID-19 booster targeting Omicron, original variants approved in U.K.

British drug regulators have become the first in the world to authorize an updated version of Moderna's coronavirus vaccine that aims to protect against the original virus and the omicron variant.

2 years ago·Canada

Read Full Article